Replies to post #512453 on NorthWest Biotherapeutics Inc (NWBO)

[Hspooner]

Right on point Doc logic, there are many posters on this site, always willing to offer an ill informed opinion without having a true grasp of the incredible science behind DCVax and the monumental work LL is conducting at UCLA. It’s all documented on YouTube in chronological order for all those investors willing to take the the time to watch the presentations and listen to LL. This platform technology is on the order of Apple, Google, and Amazon. GLTA and god bless!!

[Idunno]

Thanks, DocL, as always. … I liked this part best, (copy n pasted) from you: “This platform will reach quickly into label extensions and Direct and or an L/Direct synergistic combo will completely change cancer treatment. Big picture…”

#[e-mail]. Or, just BO. But, really, why sell out. Thinking out loud. Imo. Big picture?? Fingers crossed to all. Best.

[HyGro]

Well many investors are not buying the Phase 3 trial -- share price is down ~50% in 52 weeks after the TLD. That is clearly a "big picture." I've been in biopharma 20+ years and hold 20+ biotech stock. The big picture has only one real hurdle that makes or breaks a biotech -- a successful pivotal trial that lead to commercial approval. Nothing else matters. Many biotechs have quality contract manufacturers, as has been the case with NWBO. All management has done is finance LP's contract manufacturing business in UK.

My focus has been approvability, and that's clearly an serious issue with NWBO.